Ignite Creation Date:
2024-06-16 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06456736
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-13
First Post:
2024-06-06
Brief Title:
Clinical Features and Prognostic Markers in Adult Patients With AE Requiring ICU Treatment
Sponsor:
Central South University
Organization:
Central South University
Study Overview
Official Title:
Clinical Features and Prognostic Markers in Adult Patients With AE Requiring ICU Treatment
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Autoimmune encephalitis AE is a potentially life-threatening inflammation of the central nervous system CNS and constitutes 20-30 of encephalitis cases in adults AE often leads to subacute severe and debilitating encephalitis necessitating long-term management in a neurologic intensive care unit ICU This study aims to explore the predictive factors for poor clinical outcomes by analyzing the clinical characteristics and prognosis of adult patients with critical AE requiring ICU admission Prospective observational single center study in neurologic ICU the second Xiangya hospital Central South University All patients admitted to the ICU for probable or confirmed AE 2022 Chinese guidelines for diagnosis and treatment of AE will be included Factors associated with a poor prognosis will be identified by multivariate analysis using a logistic regression
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None